CONMED Corporation
CNMD
$44.50
$1.082.49%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.70% | 3.09% | 2.88% | 5.78% | 3.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.70% | 3.09% | 2.88% | 5.78% | 3.98% |
| Cost of Revenue | 7.77% | 0.38% | 1.01% | 3.38% | 2.52% |
| Gross Profit | 5.88% | 5.27% | 4.37% | 7.63% | 5.13% |
| SG&A Expenses | 9.64% | 5.05% | 11.54% | 2.59% | 3.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.37% | 2.46% | 5.58% | 2.56% | 3.41% |
| Operating Income | -5.27% | 7.88% | -22.43% | 27.54% | 8.29% |
| Income Before Tax | -92.43% | -20.25% | -69.82% | 7.27% | 178.36% |
| Income Tax Expenses | -81.07% | 12.74% | -71.35% | 29.89% | 68.11% |
| Earnings from Continuing Operations | -94.16% | -28.54% | -69.37% | 2.07% | 209.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -94.16% | -28.54% | -69.37% | 2.07% | 209.30% |
| EBIT | -5.27% | 7.88% | -22.43% | 27.54% | 8.29% |
| EBITDA | -2.48% | 6.68% | -13.58% | 20.38% | 5.71% |
| EPS Basic | -94.18% | -28.85% | -69.56% | 1.53% | 208.13% |
| Normalized Basic EPS | -1.65% | 14.68% | -27.00% | 36.82% | 14.08% |
| EPS Diluted | -94.27% | -28.13% | -69.84% | 2.79% | 214.00% |
| Normalized Diluted EPS | -1.13% | 15.38% | -26.26% | 39.13% | 16.62% |
| Average Basic Shares Outstanding | 0.32% | 0.44% | 0.63% | 0.54% | 0.37% |
| Average Diluted Shares Outstanding | -0.20% | -0.17% | -0.39% | -1.13% | -1.82% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 16.21% | 0.41% | 2.28% | -0.02% | -0.68% |